CareDx (CDNA) Gross Margin (2013 - 2026)

CareDx (CDNA) posted Gross Margin of 87.94% for Q2 2026, up 2.88% sequentially from 85.47% in Q1 2026, and up 571.0% YoY from 13.11% in Q2 2025.

CareDx (CDNA) Gross Margin (2013 - 2026) Analysis & Trends

CareDx has reported Gross Margin for 14 years, with the latest figure at 87.94% in Q2 2026.

Quarterly Gross Margin rose 571.0% year-over-year to 87.94% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 85.91% (up 298.0% YoY) and the FY2025 annual result came in at 83.66%, up 32.0% from the prior year.
Gross Margin rose to 87.94% in Q2 2026 per CDNA's latest filing, from 85.47% in the prior quarter.
Over five years, Gross Margin peaked at 87.94% in Q2 2026 and troughed at 77.35% in Q4 2022.
A 5-year average of 81.57% and a median of 81.62% in 2024 frame the typical range for Gross Margin.
The sharpest annual moves came in 2024 and 2025: Gross Margin jumped 629 bps in 2024, then plunged 227 bps in 2025.
Over 5 years, Gross Margin stood at 77.35% in 2022, then grew by 2 bps to 78.95% in 2023, then grew by 6 bps to 83.57% in 2024, then grew by 1 bps to 84.48% in 2025, then climbed by 4 bps to 87.94% in 2026.
According to Business Quant data, Gross Margin over the past three periods registered 87.94%, 85.47%, and 84.48% for Q2 2026, Q1 2026, and Q4 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Gross Margin (Qtr)
1	Thermo Fisher Scientific	213.88 Bn	209.81 Bn	8.34 Bn	69.57%
2	Danaher	140.65 Bn	136.30 Bn	3.61 Bn	57.64%
3	Idexx Laboratories	46.02 Bn	45.83 Bn	779.09 Mn	64.04%
4	Agilent Technologies	39.85 Bn	38.05 Bn	990.00 Mn	53.95%
5	Iqvia Holdings	39.20 Bn	37.12 Bn	1.44 Bn	32.85%
6	Natera	38.80 Bn	37.70 Bn	696.04 Mn	99.91%
7	Illumina	30.11 Bn	28.94 Bn	770.00 Mn	66.44%
8	Mettler Toledo International	28.66 Bn	28.61 Bn	650.22 Mn	63.29%
9	Quest Diagnostics	26.24 Bn	25.61 Bn	1.03 Bn	33.75%
10	CareDx	2.35 Bn	1.98 Bn	116.03 Mn	87.94%

Download Data